Skip to content

Paul F Daley

Department of Pharmacology (N.D., S.B., A.A., L.L.I.), Michigan Psychedelic Center (M-PsyC) (N.D., L.L.I.), Life Sciences Institute (C.C.H., A.A.), University of Michigan, Ann Arbor, Michigan; Promega Corporation, Fitchburg, Wisconsin (R.F.O.); Usona Institute, Fitchburg, Wisconsin (A.M.S.); Department of Cell Biology, Neurobiology, and Anatomy. Medical College of Wisconsin, Milwaukee, Wisconsin (H.A.B., J.D.M.); Department of Neurology and Neurologic Sciences, Stanford University, Stanford, California (J.M.H.); and Alexander Shulgin Research Institute, Lafayette, California (P.F.D., W.B.C., N.V.C.).

1 paper in the library · 43 citations · publishing 2018

Papers

Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.

Neuropharmacology November 1, 2018 Landon M Klein, Nicholas V Cozzi, Paul F Daley et al. 43 citations

Most DALT derivatives bind to several serotonin receptors, sigma sites, and other targets. In mice, several compounds triggered the head-twitch response, a behavioral proxy for hallucinogen effects, with 4-acetoxy-DALT being most potent, followed by 5-fluoro-DALT, 5-methoxy-DALT, 4-hydroxy-DALT, DALT, and 5-bromo-DALT; four derivatives did not induce the response. Head-twitch potency was not linked to binding affinity at either 5-HT1A or 5-HT2A receptors alone, but a regression analysis showed that 5-HT2A receptors contribute positively and 5-HT1A receptors contribute negatively to potency, explaining 87% of the variance. These results support the role of 5-HT2A receptors in the head-twitch response and suggest that 5-HT1A activation by tryptamine hallucinogens dampens this effect.